|
2019
|
Invention
|
Substituted pyrimidines for inhibiting embryonic leucine zipper kinase activity. Compounds having... |
|
|
Invention
|
Pyrazolyl compounds and methods of use thereof. Compounds having activity as chemotherapeutic age... |
|
2015
|
Invention
|
Substituted 1 h-pyrrolo [2, 3-b] pyridine and 1 h-pyrazolo [3, 4-b] pyridine derivatives as salt ... |
|
|
Invention
|
Substituted 1h-pyrrolo [2, 3-b] pyridine and 1h-pyrazolo [3, 4-b] pyridine derivatives as salt in... |
|
|
Invention
|
Substituted pyrrolo[2,3-b]pyrazines and substituted pyrazolo[3,4-b]pyridines as itk and jak kinas... |
|
|
Invention
|
Substituted 5-(pyrazin-2-yl)-1h-pyrazolo [3, 4-b] pyridine and pyrazolo [3, 4-b] pyridine derivat... |
|
|
Invention
|
B] pyridine derivatives as protein kinase inhibitors. Substituted 5-(pyrazin-2-yl)-1H-pyrazolo[3,... |
|
2014
|
Invention
|
Substituted 2, 3-dihydro-1h-inden-1-one retinoic acid-related orphan nuclear receptor antagonists... |
|
|
Invention
|
3,5-(un)substituted-1h-pyrrolo[2,3-b]pyridine, 1h-pyrazolo[3,4-b]pyridine and 5h-pyrrolo [2-,3-b]... |
|
|
Invention
|
3,5-(un)substituted-1h-pyrrolo[2,3-b]pyridine, 1h-pyrazolo[3,4-b]pyridine and 5h-pyrrolo[2,3-b]py... |
|
|
Invention
|
B]pyridines as itk and jak inhibitors. The present invention relates to compounds described by Fo... |
|
2013
|
Invention
|
Substituted 1h-pyrrolo [2,3-b] pyridine and 1h-pyrazolo [3, 4-b] pyridine derivatives as salt ind... |
|
|
Invention
|
Substituted 1h-pyrrolo[2,3-b]pyridine and 1h-pyrazolo[3,4-b]pyridine derivatives as salt inducibl... |
